Medifast (MED) Stock Price, News & Analysis

Company Overview

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Key Stats

• Today's Range: $13.01 to $13.41
• 50-Day Range: $12.69 to $15.22
• 52-Week Range: $11.57 to $21.98
• Volume: 90,017 shs
• Average Volume: 227,895 shs
• Market Capitalization: $144.90 million
• P/E Ratio: 41.29
• Dividend Yield: N/A
• Price Target: $16.50
• Consensus Rating: Hold

Medifast Stock Analysis - MarketRank™

Medifast scored higher than 83% of companies evaluated by MarketBeat, and ranked 43rd out of 153 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Medifast has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Medifast has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 200.00%

Earnings Growth

Earnings for Medifast are expected to grow by 200.00% in the coming year, from $0.51 to $1.53 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medifast is 41.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.72.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medifast is 41.00, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 19.13.

Price to Book Value per Share Ratio

Medifast has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

21.87% of the float of Medifast has been sold short.

Short Interest Ratio / Days to Cover

Medifast has a short interest ratio ("days to cover") of 9.8.

Change versus previous month

Short interest in Medifast has recently increased by 2.69%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Medifast does not currently pay a dividend.

Dividend Growth

Medifast does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 2.0 / 5
• Environmental Score: -4.00

Percentage of Shares Shorted

21.87% of the float of Medifast has been sold short.

Short Interest Ratio / Days to Cover

Medifast has a short interest ratio ("days to cover") of 9.8.

Change versus previous month

Short interest in Medifast has recently increased by 2.69%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.11

News Sentiment

Medifast has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Medifast this week, compared to 3 articles on an average week.

Search Interest

6 people have searched for MED on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Medifast insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,003.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 2.90% of the stock of Medifast is held by insiders.

Percentage Held by Institutions

95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MED Stock Analysis - Frequently Asked Questions

How have MED shares performed this year?

Medifast's stock was trading at $17.62 on January 1st, 2025. Since then, MED shares have decreased by 25.8% and is now trading at $13.08.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) announced its quarterly earnings results on Monday, August, 4th. The specialty retailer reported $0.04 EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.26. The specialty retailer earned $105.56 million during the quarter, compared to analysts' expectations of $96.10 million. Medifast had a trailing twelve-month return on equity of 2.00% and a net margin of 0.76%.
Read the conference call transcript.

Who are Medifast's major shareholders?

Top institutional investors of Medifast include Acadian Asset Management LLC (3.74%), Bank of America Corp DE (3.61%), Geode Capital Management LLC (2.31%) and American Century Companies Inc. (1.95%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist.
View institutional ownership trends.

How do I buy shares of Medifast?

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AU Optronics (AUOTY).

Company Calendar

• Last Earnings: 8/04/2025
• Today: 8/15/2025
• Next Earnings (Estimated): 11/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: FOOD - MISC/DIVERSIFIED
• Sub-Industry: Personal Products
• Current Symbol: NYSE:MED
• CIK: 910329
• Web: www.medifast1.com
• Phone: (410) 581-8042
• Fax: 410-581-8070
• Employees: 870
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Medifast: $16.50
• High Price Target: $16.50
• Low Price Target: $16.50
• Potential Upside/Downside: +26.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.32
• Trailing P/E Ratio: 41.00
• Forward P/E Ratio: 25.65
• P/E Growth: N/A
• Net Income: $2.09 million
• Net Margins: 0.76%
• Pretax Margin: 1.30%
• Return on Equity: 2.00%
• Return on Assets: 1.50%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.47
• Quick Ratio: 3.82

Sales & Book Value

• Annual Sales: $602.46 million
• Price / Sales: 0.24
• Cash Flow: $2.81 per share
• Price / Cash Flow: 4.66
• Book Value: $19.65 per share
• Price / Book: 0.67

Miscellaneous

• Outstanding Shares: 10,990,000
• Free Float: 10,672,000
• Market Cap: $143.75 million
• Optionable: Optionable
• Beta: 0.80